Trademark: 88922039
Word
KANTARO
Status
Registered
Status Code
700
Status Date
Tuesday, March 8, 2022
Serial Number
88922039
Registration Number
6667510
Registration Date
Tuesday, March 8, 2022
Mark Type
4000
Filing Date
Monday, May 18, 2020
Published for Opposition
Tuesday, May 18, 2021

Trademark Owner History
Kantaro Biosciences LLC - Original Registrant

Classifications
10 Medical diagnostic testing and analysis equipment and apparatus for performing serological, molecular polymerase chain reaction (PCR), antigen and antibody tests, namely, medical diagnostic apparatus for testing for infections, viruses, disorders and diseases; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens and tissue; Apparatus for analysis of biological materials for medical purposes; Medical apparatus and instruments for diagnostic analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics for detecting, measuring and analyzing DNA, RNA, antibodies, enzymes, antigens, viral, infectious, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases, viruses and infections for medical and clinical purposes; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Kits for testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue for medical purposes; Medical diagnostic apparatus and devices for detecting SARS-CoV-2 and COVID-19; Diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical bags, pouches and containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens and tissue obtained from humans

Trademark Events
Mar 8, 2022
Registered-Principal Register
Feb 1, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 31, 2022
Allowed Principal Register - Sou Accepted
Jan 28, 2022
Statement Of Use Processing Complete
Jan 13, 2022
Use Amendment Filed
Jan 28, 2022
Case Assigned To Intent To Use Paralegal
Jan 13, 2022
Teas Statement Of Use Received
Jul 13, 2021
Noa E-Mailed - Sou Required From Applicant
May 18, 2021
Official Gazette Publication Confirmation E-Mailed
May 18, 2021
Published For Opposition
Apr 28, 2021
Notification Of Notice Of Publication E-Mailed
Apr 13, 2021
Approved For Pub - Principal Register
Apr 13, 2021
Examiner's Amendment Entered
Apr 13, 2021
Notification Of Examiners Amendment E-Mailed
Apr 13, 2021
Examiners Amendment E-Mailed
Apr 13, 2021
Examiners Amendment -Written
Apr 1, 2021
Assigned To Examiner
Mar 1, 2021
Teas/Email Correspondence Entered
Feb 26, 2021
Correspondence Received In Law Office
Feb 26, 2021
Teas Response To Office Action Received
Nov 8, 2020
Notification Of Non-Final Action E-Mailed
Nov 8, 2020
Non-Final Action E-Mailed
Nov 8, 2020
Non-Final Action Written
Nov 7, 2020
Assigned To Examiner
Jun 3, 2020
New Application Office Supplied Data Entered In Tram
May 21, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24